Trisomy of chromosome 21 in leukemogenesis

Blood Cells, Molecules, and Diseases

Volumn 39, Issue 2, 2007, Pages 156-159

  Izraeli, Shai ^a,b   Rainis, Liat ^a,b   Hertzberg, Libi ^a,b   Smooha, Gil ^a,b   Birger, Yehudit ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute lymphoblastic leukemia; Childhood leukemia; Chromosome 21; Down syndrome; GATA1; Megakaryoblastic leukemia

Indexed keywords

TRANSCRIPTION FACTOR GATA 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; ANEUPLOIDY; ARTICLE; CANCER GENETICS; CANCER RISK; CHILDHOOD LEUKEMIA; DISEASE ASSOCIATION; DOWN SYNDROME; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; LEUKEMOGENESIS; MEGAKARYOBLAST; PRIORITY JOURNAL;

CHILD; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; TRISOMY;

EID: 34547203007     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.04.004     Document Type: Article

References (27)

1. Roschke A.V., Tonon G., Gehlhaus K.S., McTyre N., Bussey K.J., Lababidi S., Scudiero D.A., Weinstein J.N., and Kirsch I.R. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res. 63 (2003) 8634-8647
2. Forestier E., Heim S., Blennow E., Borgstrom G., Holmgren G., Heinonen K., Johannsson J., Kerndrup G., Andersen M.K., Lundin C., Nordgren A., Rosenquist R., Swolin B., and Johansson B. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001. Br. J. Haematol. 121 (2003) 566-577
3. Harrison C.J. The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Blood Rev. 15 (2001) 49-59
4. Ross M.E., Zhou X., Song G., Shurtleff S.A., Girtman K., Williams W.K., Liu H.C., Mahfouz R., Raimondi S.C., Lenny N., Patel A., and Downing J.R. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102 (2003) 2951-2959
5. Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol. 2 (2001) 429-436
6. Wechsler J., Greene M., McDevitt M.A., Anastasi J., Karp J.E., Le Beau M.M., and Crispino J.D. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 32 (2002) 148-152
7. Rainis L., Bercovich D., Strehl S., Teigler-Schlegel A., Stark B., Trka J., Amariglio N., Biondi A., Muler I., Rechavi G., Kempski H., Haas O.A., and Izraeli S. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102 (2003) 981-986
8. Taub J.W., Mundschau G., Ge Y., Poulik J.M., Qureshi F., Jensen T., James S.J., Matherly L.H., Wechsler J., and Crispino J.D. Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome. Blood 104 (2004) 1588-1589
9. Crispino J.D. GATA1 in normal and malignant hematopoiesis. Semin. Cell Dev. Biol. 16 (2005) 137-147
10. Rainis L., Toki T., Pimanda J.E., Rosenthal E., Machol K., Strehl S., Gottgens B., Ito E., and Izraeli S. The proto-oncogene ERG in megakaryoblastic leukemias. Cancer Res. 65 (2005) 7596-7602
11. Hertzberg L., Betts D.R., Raimondi S.C., Schafer B.W., Notterman D.A., Domany E., and Izraeli S. Prediction of chromosomal aneuploidy from gene expression data. Genes Chromosomes Cancer 46 (2007) 75-86
12. Ichikawa M., Asai T., Saito T., Yamamoto G., Seo S., Yamazaki I., Yamagata T., Mitani K., Chiba S., Ogawa S., Kurokawa M., and Hirai H. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10 (2004) 299-304
13. Elagib K.E., Racke F.K., Mogass M., Khetawat R., Delehanty L.L., and Goldfarb A.N. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood 101 (2003) 4333-4341
14. Garzon R., Pichiorri F., Palumbo T., Iuliano R., Cimmino A., Aqeilan R., Volinia S., Bhatt D., Alder H., Marcucci G., Calin G.A., Liu C.G., Bloomfield C.D., Andreeff M., and Croce C.M. MicroRNA fingerprints during human megakaryocytopoiesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5078-5083
15. Kivivuori S.M., Rajantie J., and Siimes M.A. Peripheral blood cell counts in infants with Down's syndrome. Clin. Genet. 49 (1996) 15-19
16. Li Z., Godinho F.J., Klusmann J.H., Garriga-Canut M., Yu C., and Orkin S.H. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat. Genet. 37 (2005) 613-619
17. Greaves M. Pre-natal origins of childhood leukemia. Rev. Clin. Exp. Hematol. 7 (2003) 233-245
18. Hasle H., Niemeyer C.M., Chessells J.M., Baumann I., Bennett J.M., Kerndrup G., and Head D.R. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 17 (2003) 277-282
19. Ravindranath Y. Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment. Pediatr. Blood Cancer 44 (2005) 1-7
20. Ross J.A., Spector L.G., Robison L.L., and Olshan A.F. Epidemiology of leukemia in children with Down syndrome. Pediatr. Blood Cancer 44 (2005) 8-12
21. Zeller B., Gustafsson G., Forestier E., Abrahamsson J., Clausen N., Heldrup J., Hovi L., Jonmundsson G., Lie S.O., Glomstein A., and Hasle H. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Br. J. Haematol. 128 (2005) 797-804
22. Einav U., Tabach Y., Getz G., Yitzhaky A., Ozbek U., Amariglio N., Izraeli S., Rechavi G., and Domany E. Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer. Oncogene 24 (2005) 6367-6375
23. Greaves M.F. Aetiology of acute leukaemia. Lancet 349 (1997) 344-349
24. Pui C.H., Campana D., and Evans W.E. Childhood acute lymphoblastic leukaemia - current status and future perspectives. Lancet Oncol. 2 (2001) 597-607
25. Bassal M., La M.K., Whitlock J.A., Sather H.N., Heerema N.A., Gaynon P.S., and Stork L.C. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952. Pediatr. Blood Cancer 44 (2005) 21-28
26. + acute lymphoblastic leukemia in children with and without Down syndrome. Pediatr. Hematol. Oncol. 22 (2005) 11-16
27. Mullighan C.G., Goorha S., Radtke I., Miller C.B., Coustan-Smith E., Dalton J.D., Girtman K., Mathew S., Ma J., Pounds S.B., Su X., Pui C.H., Relling M.V., Evans W.E., Shurtleff S.A., and Downing J.R. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature (2007)